Citadel Advisors
EXAS

Citadel Advisors’s Exact Sciences EXAS Stock Holding History

Citadel Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-83,025
Closed -$8.43M – 13312
2025
Q4 		$8.43M Sell
83,025
-3,858,562
-98% -$310M ﹤0.01% 3482
2025
Q3 		$216M Buy
3,941,587
+3,506,084
+805% +$175M 0.03% 449
2025
Q2 		$23.1M Buy
435,503
+206,449
+90% +$10.5M ﹤0.01% 1977
2025
Q1 		$9.92M Sell
229,054
-39,590
-15% -$2M ﹤0.01% 2860
2024
Q4 		$15.1M Buy
268,644
+257,915
+2,404% +$16.1M ﹤0.01% 2480
2024
Q3 		$731K Sell
10,729
-450,613
-98% -$25.4M ﹤0.01% 7461
2024
Q2 		$19.5M Sell
461,342
-1,592,855
-78% -$87.6M ﹤0.01% 2026
2024
Q1 		$142M Sell
2,054,197
-685,487
-25% -$43.4M 0.03% 516
2023
Q4 		$203M Buy
2,739,684
+1,043,452
+62% +$68.4M 0.04% 342
2023
Q3 		$116M Sell
1,696,232
-745,502
-31% -$63.3M 0.02% 556
2023
Q2 		$229M Buy
2,441,734
+761,728
+45% +$59.4M 0.05% 271
2023
Q1 		$114M Buy
1,680,006
+434,876
+35% +$28M 0.03% 561
2022
Q4 		$61.6M Sell
1,245,130
-65,193
-5% -$2.66M 0.01% 968
2022
Q3 		$42.6M Sell
1,310,323
-1,219,387
-48% -$50.3M 0.01% 1193
2022
Q2 		$99.6M Buy
2,529,710
+2,509,427
+12,372% +$134M 0.03% 577
2022
Q1 		$1.42M Sell
20,283
-236,699
-92% -$17.3M ﹤0.01% 6871
2021
Q4 		$20M Sell
256,982
-317,189
-55% -$28M ﹤0.01% 2024
2021
Q3 		$54.8M Buy
574,171
+479,305
+505% +$50.6M 0.01% 1055
2021
Q2 		$11.8M Buy
94,866
+4,413
+5% +$527K ﹤0.01% 2824
2021
Q1 		$11.9M Sell
90,453
-80,849
-47% -$11.1M ﹤0.01% 2722
2020
Q4 		$22.7M Sell
171,302
-126,007
-42% -$15.2M 0.01% 1668
2020
Q3 		$30.3M Sell
297,309
-838,623
-74% -$72.4M 0.01% 1215
2020
Q2 		$98.8M Buy
1,135,932
+957,741
+537% +$76.5M 0.04% 414
2020
Q1 		$10.3M Buy
178,191
+83,228
+88% +$6.76M ﹤0.01% 1813
2019
Q4 		$8.78M Sell
94,963
-408,591
-81% -$35.9M ﹤0.01% 2341
2019
Q3 		$45.5M Buy
503,554
+377,934
+301% +$43.1M 0.02% 814
2019
Q2 		$14.8M Buy
125,620
+90,087
+254% +$9.08M 0.01% 1713
2019
Q1 		$3.08M Sell
35,533
-207,876
-85% -$17.7M ﹤0.01% 3713
2018
Q4 		$15.4M Buy
243,409
+199,297
+452% +$13.7M 0.01% 1448
2018
Q3 		$3.48M Sell
44,112
-765,952
-95% -$49.9M ﹤0.01% 3500
2018
Q2 		$48.4M Buy
810,064
+584,144
+259% +$31.4M 0.02% 727
2018
Q1 		$9.11M Buy
225,920
+77,944
+53% +$3.8M 0.01% 1821
2017
Q4 		$7.78M Sell
147,976
-33,674
-19% -$1.8M ﹤0.01% 1986
2017
Q3 		$8.56M Sell
181,650
-40,470
-18% -$1.63M 0.01% 1741
2017
Q2 		$7.86M Buy
+222,120
New +$6.86M 0.01% 1654
2017
Q1 		– Sell
-198,774
Closed -$3.94M – 7597
2016
Q4 		$2.65M Buy
198,774
+112,715
+131% +$1.82M ﹤0.01% 2628
2016
Q3 		$1.6M Buy
86,059
+49,176
+133% +$867K ﹤0.01% 3232
2016
Q2 		$452K Sell
36,883
-55,034
-60% -$415K ﹤0.01% 4635
2016
Q1 		$619K Buy
91,917
+50,003
+119% +$320K ﹤0.01% 4104
2015
Q4 		$387K Sell
41,914
-52,739
-56% -$490K ﹤0.01% 4829
2015
Q3 		$1.7M Buy
94,653
+67,229
+245% +$1.54M ﹤0.01% 3147
2015
Q2 		$816K Sell
27,424
-35,731
-57% -$898K ﹤0.01% 4255
2015
Q1 		$1.39M Buy
+63,155
New +$1.6M ﹤0.01% 3531
2014
Q4 		– Sell
-23,835
Closed -$580K – 8539
2014
Q3 		$462K Buy
+23,835
New +$437K ﹤0.01% 4727
2014
Q2 		– Sell
-37,976
Closed -$523K – 8042
2014
Q1 		$538K Buy
37,976
+5,560
+17% +$75.1K ﹤0.01% 4250
2013
Q4 		$379K Sell
32,416
-11,903
-27% -$137K ﹤0.01% 4338
2013
Q3 		$523K Buy
44,319
+35,171
+384% +$451K ﹤0.01% 3767
2013
Q2 		$127K Buy
+9,148
New +$99.4K ﹤0.01% 5039

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citadel Advisors's EXAS Position: Q1 2026 in Review

Citadel Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 83,025 shares — an estimated $8.43M sold.

Citadel Advisors first reported a position in EXAS in Q2 2013 and held it in 48 quarters. The position peaked at $229M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citadel Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 83,025 Exact Sciences shares in Q1 2026, an estimated $8.43M.
  • Citadel Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 48 quarters.
  • Citadel Advisors's Exact Sciences position peaked at $229M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.